Category — Biotechnology

India’s Proklean Tech’s Probiotic Products Find Global Markets

Chennai, India-based Proklean Technologies, has an exclusive license from Kansas City’s SCD Probiotics for using its certified mother culture to manufacture and market products that are natural, non-toxic, and bio-degradable. These products are used in variety of industries, including leather and textile processing. “Wherever chemical surfactants are used, we have an opportunity to develop a replacement,” says Sivaram Pillai, the CEO of the company.

BusinessLine reports that according to the agreement, SCD Probiotics will sell the product made in India for the leather industry globally, while Proklean will sell it in the Indian market. For the textiles processing industry, Proklean will sell the products in India and globally too. “We are selling in Bangladesh, the Philippines, Sri Lanka and we are starting Indonesia,” says Vishwadeep Kuila, director, Proklean.

Proklean Products

This year, Proklean will launch products for the paper and pulp industry. “We are ready with the first product for the paper industry, which will help reduce the usage of chemicals, or with the same chemical consumption, increase the brightness of paper,” Pillai said. These products help bring down water consumption by 20 percent, reduce pollution by 30 percent and processing time by 10 percent, added Pillai.

 

June 15, 2017   No Comments

Jubilant Pharma Expected to Buy American Pharma Company

Noida, India-based Jubilant Life Sciences‘ subsidiary Jubilant Pharma will negotiate a potential acquisition of a specialty business in the U.S., subject to due diligence, satisfactory agreements, and final approval of Jubilant Life Sciences.

A vial of medicine for injection

 

BusinessLine reports on a company filing at the Bombay Stock Exchange that says, “the proposed acquisition is a niche, profitable specialty pharma business with a strategic fit and is expected to provide a competitive edge for Jubilant Life Sciences’ existing business, if it materializes.”

June 11, 2017   No Comments

Shell Inaugurates Technology Center in India

British-Dutch oil and gas multinational Shell opened a new major technology hub in Bangalore — a 52 acre, custom-built facility – that can house up to 1,500 scientists and engineers, who will  work on worldwide innovative energy projects.

This third center, which is similar to those in Amsterdam and Houston, will have specialists who will work closely with experts from external industrial partners, universities, and institutes. In India, chemistry and catalysis research is done in collaboration with the Indian Institutes of Technology.

“Collaboration is essential to meet our biggest challenge: timely development and deployment of the best and affordable energy solutions, for today and for the future as the world transitions to a low carbon energy system,” said Harry Brekelmans, Shell’s Projects & Technology Director.

Shell Logo on a canopy

Using its IH2 (waste to fuel) technology, this center will help pioneer efforts to turn forestry, agricultural and city-generated waste into transportation fuels, with a new demonstration plant built at the site, reports the Economic Times.

“The center is slated to play a prominent role in Shell India’s aspiration to custom-build a portfolio of new energy solutions specifically suited to India’s energy challenges,” Nitin Prasad, Chairman of Shell Companies in India, said.

June 8, 2017   No Comments

India Launches National Pharma Mission

The Government of India launched the National Pharma Mission for the development of bio pharmaceuticals through industry-academia collaboration. This program will focus on the development of specific products such as vaccines, biotherapeutics, and newer platform technologies for medical devices and diagnostics.

Funded by India’s central government and through a loan from the World Bank, the Mission will be implemented by the Biotechnology Industry Research Assistance Council (BIRAC), a unit of the  Department of Biotechnology. Renu Swarup, managing director of BIRAC said, “This mission is not for new discovery, but for creating infrastructure to move important early leads, which are in different stages, through the pipeline, and create products.”

Research

The National Biotechnology Development Strategy 2015-2020 announced by the Department of Biotechnology lays emphasis on making India ready to meet the challenge of achieving a $100 billion biotech industry by 2025, reports the Indian Express.

June 8, 2017   No Comments

India’s Parry Nutraceuticals Gets USFDA Approval

Based in India’s southern state of Tamil Nadu, Parry Nutraceuticals received the U.S. Food and Drug Administration approval for its India facility for organic micro-algae cultivation and processing.

Business head, Parry Nutraceuticals, Muthu Murugappan said that some of the products that they planned to bring to market over the next two years include Organic Chlorella, Spirulina Granules, CO2 Extracted Lutein and Algal Beta Glucan. New areas currently under development include vegan algal proteins, chlorophyll and algae  omega-3s, reports Outlook.

Parry Nutraceuticals Logo

Valensa International, based in Florida, which specializes in the development of condition-specific nutraceuticals such as joint, eye and cardio-vascular health issues, is a wholly owned subsidiary of Parry.

June 5, 2017   No Comments